Assignee
APOTEX INC
CA·62 granted patents·23 pending applications·476 citations·filing 1993–2024
Top patents by PatentIndex Score
85 records- 0195US11377456B2Crystalline form of RemdesivirAPOTEX INC·Filed 2021·Granted Jul 5, 2022·16 cites·21 claims
- 0291US10800787B2Process for the preparation of acalabrutinibAPOTEX INC·Filed 2018·Granted Oct 13, 2020·9 cites·10 claims
- 0391US6426418B1Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamideAPOTEX INC·Filed 2001·Granted Jul 30, 2002·38 cites·5 claims
- 0486US10016423B2Solid forms of nilotinib hydrochlorideAPOTEX INC·Filed 2015·Granted Jul 10, 2018·8 cites·19 claims
- 0586US5908959AProcess for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereofAPOTEX INC·Filed 1998·Granted Jun 1, 1999·42 cites·11 claims
- 0685US5393893AProcess for producing simvastatin and analogs thereofAPOTEX INC·Filed 1993·Granted Feb 28, 1995·43 cites·17 claims
- 0784US10487059B2Crystalline form of EluxadolineAPOTEX INC·Filed 2018·Granted Nov 26, 2019·2 cites·7 claims
- 0884US10183024B2Crystalline forms of ibrutinibAPOTEX INC·Filed 2017·Granted Jan 22, 2019·2 cites·5 claims
- 0982US9376419B2Solid forms of nilotinib hydrochlorideAPOTEX INC·Filed 2013·Granted Jun 28, 2016·6 cites·18 claims
- 1082US6245903B1Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereofAPOTEX INC·Filed 1999·Granted Jun 12, 2001·66 cites·9 claims
- 1181US9944616B2Processes for the preparation of Tasimelteon and intermediates thereofAPOTEX INC·Filed 2017·Granted Apr 17, 2018·2 cites·20 claims
- 1281US9260438B2Solid forms of tofacitinib saltsAPOTEX INC·Filed 2015·Granted Feb 16, 2016·3 cites·4 claims
- 1380US11236066B2Crystalline forms of niraparib tosylateAPOTEX INC·Filed 2020·Granted Feb 1, 2022·1 cites·20 claims
- 1479US10513504B2Processes for the preparation of apalutamide and intermediates thereofAPOTEX INC·Filed 2019·Granted Dec 24, 2019·2 cites·19 claims
- 1578US11046638B2Processes for the preparation of zuclomiphene and intermediates thereofAPOTEX INC·Filed 2020·Granted Jun 29, 2021·1 cites·17 claims
- 1677US6476229B1Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamideAPOTEX INC·Filed 2002·Granted Nov 5, 2002·8 cites·3 claims
- 1776US6472532B1Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-OXO-1,4-dihydropyridine-2-carboxamideAPOTEX INC·Filed 2002·Granted Oct 29, 2002·7 cites·3 claims
- 1875US7049328B2Use for deferiproneAPOTEX INC·Filed 2001·Granted May 23, 2006·14 cites·20 claims
- 1974US6468977B1Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymesAPOTEX INC·Filed 2000·Granted Oct 22, 2002·12 cites·50 claims
- 2073US5847118AMethods for the manufacture of amorphous cefuroxime axetilAPOTEX INC·Filed 1997·Granted Dec 8, 1998·21 cites·6 claims
- 2172US9382233B2Forms of vilazodone and processes for the preparation thereofAPOTEX INC·Filed 2013·Granted Jul 5, 2016·1 cites·10 claims
- 2271US10513500B2Crystalline forms of LesinuradAPOTEX INC·Filed 2017·Granted Dec 24, 2019·1 cites·15 claims
- 2370US11814356B1Salt of cabozantinibAPOTEX INC·Filed 2023·Granted Nov 14, 2023·0 cites·16 claims
- 2470USRE39087EAzithromycin monohydrate isopropanol clathrate and methods for the manufacture thereofAPOTEX INC·Filed 2003·Granted May 2, 2006·3 cites·42 claims
- 2569US6506929B1Process to manufacture simvastatin and intermediatesAPOTEX INC·Filed 2001·Granted Jan 14, 2003·5 cites·17 claims
- 2668US10822309B2Crystalline form of EluxadolineAPOTEX INC·Filed 2019·Granted Nov 3, 2020·0 cites·9 claims
- 2767US5433256APill guide and dispenser trayAPOTEX INC·Filed 1994·Granted Jul 18, 1995·33 cites·12 claims
- 2865US5914401AMethods for the manufacture of quinolone carboxylic acids derivatives and intermediates thereofAPOTEX INC·Filed 1998·Granted Jun 22, 1999·11 cites·16 claims
- 2965US2024409547A1Solid Forms of UpadacitinibAPOTEX INC·Filed 2024·Application pending·0 cites
- 3064US2024116884A1Salts of ViloxazineAPOTEX INC·Filed 2023·Application pending·0 cites
- 3163US10611772B2Crystalline form of Ribociclib succinateAPOTEX INC·Filed 2019·Granted Apr 7, 2020·0 cites·11 claims
- 3263US9809551B2Solid forms of Ivacaftor and processes for the preparation thereofAPOTEX INC·Filed 2014·Granted Nov 7, 2017·3 cites·9 claims
- 3363US6060472AThiadiazole compounds useful as inhibitors of H+ /K+ atpaseAPOTEX INC·Filed 1998·Granted May 9, 2000·10 cites·21 claims
- 3463US2024018090A1Processes for the Preparation of FenfluramineAPOTEX INC·Filed 2023·Application pending·0 cites
- 3562US11220500B2Crystalline form of Valbenazine dibesylateAPOTEX INC·Filed 2019·Granted Jan 11, 2022·0 cites·18 claims
- 3662US5677302AThiadiazole compounds useful as proton pump inhibitorsAPOTEX INC·Filed 1996·Granted Oct 14, 1997·19 cites·32 claims
- 3761US7410985B2Cycloalkyl derivatives of 3-hydroxy-4-pyridinonesAPOTEX INC·Filed 2004·Granted Aug 12, 2008·1 cites·15 claims
- 3861US6114537AProcess for scavenging thiolsAPOTEX INC·Filed 1997·Granted Sep 5, 2000·20 cites·5 claims
- 3961US5900485AMethods for the manufacture of neofazodoneAPOTEX INC·Filed 1997·Granted May 4, 1999·8 cites·17 claims
- 4060US11667656B2Crystalline forms of Tenofovir alafenamideAPOTEX INC·Filed 2021·Granted Jun 6, 2023·0 cites·20 claims
- 4160US11578025B2Processes for the preparation of zuclomiphene intermediatesAPOTEX INC·Filed 2021·Granted Feb 14, 2023·0 cites·16 claims
- 4260US2025049774A1Crystalline Forms of ApalutamideAPOTEX INC·Filed 2022·Application pending·0 cites
- 4359US10662178B2Crystalline form of OlaparibAPOTEX INC·Filed 2019·Granted May 26, 2020·0 cites·14 claims
- 4459US10407396B2Crystalline form of selexipagAPOTEX INC·Filed 2018·Granted Sep 10, 2019·0 cites·19 claims
- 4559US2025019346A1Salts of Ruxolitinib and Crystalline Forms ThereofAPOTEX INC·Filed 2022·Application pending·0 cites
- 4658US10556887B2Processes for the preparation of Veliparib and intermediates thereofAPOTEX INC·Filed 2018·Granted Feb 11, 2020·0 cites·20 claims
- 4758US5723618A1,4-dihydropyridines, N-substituted bicyclic 4-hydropyridines, and bicyclic N-substituted 4,5-dihydropyridinesAPOTEX INC·Filed 1996·Granted Mar 3, 1998·7 cites·12 claims
- 4857US10066001B2Enhanced liquid formulation stability of erythropoietin alpha through purification processingAPOTEX INC·Filed 2014·Granted Sep 4, 2018·0 cites·11 claims
- 4957US6024247ADeblistering machineAPOTEX INC·Filed 1997·Granted Feb 15, 2000·25 cites·4 claims
- 5055US11980622B1Oxcarbazepine extended release dosage formAPOTEX INC·Filed 2022·Granted May 14, 2024·0 cites·23 claims
Showing the top 50 of 85 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →